Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.YJMCC.2003.10.016PMID 15010275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3.

  2003cited by this paper
• Induction of cyclooxygenase‐1 and ‐2 modulates angiogenic responses to engagement of αvβ3

  2003cited by this paper
• Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha.

  2002cited by this paper
• Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide Synthesis

  2002cited by this paper
• Hypoxia Up-regulates Expression of Peroxisome Proliferator-activated Receptor γ Angiopoietin-related Gene (PGAR) in Cardiomyocytes: Role of Hypoxia Inducible Factor 1α

  2002cited by this paper
• Has angiogenesis been invited to the PPARty?

  2002influential reference
• The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.

  2002cited by this paper
• The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling

  2002cited by this paper
• Isoform-specific regulation of vascular endothelial growth factor (VEGF) family mRNA expression in cultured mouse brown adipocytes.

  2001cited by this paper
• Oxidized LDL Regulates Vascular Endothelial Growth Factor Expression in Human Macrophages and Endothelial Cells Through Activation of Peroxisome Proliferator–Activated Receptor-&ggr;

  2001cited by this paper
• Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor.

  2001cited by this paper
• Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.

  2001cited by this paper
• Hypoxia in vivo decreases peroxisome proliferator-activated receptor alpha-regulated gene expression in rat heart.

  2001cited by this paper
• Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation.

  2001cited by this paper
• The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors

  2001cited by this paper
• Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells.

  2000cited by this paper
• Adenovirus-Mediated Human Tissue Kallikrein Gene Delivery Induces Angiogenesis in Normoperfused Skeletal Muscle

  2000cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Agonists Increase Vascular Endothelial Growth Factor Expression in Human Vascular Smooth Muscle Cells

  2000cited by this paper
• Internalization and Sequestration of the Human Prostacyclin Receptor*

  2000cited by this paper
• Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor.

  2000cited by this paper
• Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo *

  1999cited by this paper
• Effects of angiogenic growth factors on endothelium-derived prostacyclin production by ovine uterine and placental arteries.

  1999cited by this paper
• Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta.

  1999cited by this paper
• Vascular Endothelial Growth Factor Signals Endothelial Cell Production of Nitric Oxide and Prostacyclin through Flk-1/KDR Activation of c-Src*

  1999cited by this paper
• Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.

  1998cited by this paper
• Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells.

  1998cited by this paper
• Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP.

  1997cited by this paper
• Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen‐activated protein kinase

  1997cited by this paper
• The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.

  1996cited by this paper
• A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

  1995cited by this paper
• 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ

  1995cited by this paper
• cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla.

  1994cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat.

  1986cited by this paper
• Identification and characterisation of a prostacyclin-like receptor in bovine coronary arteries using a specific and stable prostacyclin analogue, ciloprost, as radioactive ligand.

  1982cited by this paper
• EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN

  1982cited by this paper
• Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.

  1980cited by this paper
• Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.

  1977cited by this paper

• Prostacyclin Assists in the Repair of Ruptured Amnions through the Proliferation and Migration of Amnion Mesenchymal Cells

  2025cites this paper
• ILOBONE: A phase I/IIa randomized controlled trial to assess the safety and feasibility of local iloprost therapy for enhancing proximal humerus fracture healing– a pilot study design

  2025cites this paper
• Plasma CXCL4–DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment

  2024cites this paper
• Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in bmpr2‐silenced human lung microvascular endothelial cells

  2023cites this paper
• Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma

  2023cites this paper
• Angiogenesis Induction as a Key Step in Cardiac Tissue Regeneration: From Angiogenic agents to Biomaterials.

  2023cites this paper
• PTGIS May Be a Predictive Marker for Ovarian Cancer by Regulating Fatty Acid Metabolism

  2023cites this paper
• Maternal Fatty Acid Metabolism in Pregnancy and Its Consequences in the Feto-Placental Development

  2022cites this paper
• Prostacyclin as a Negative Regulator of Angiogenesis in the Neurovasculature

  2021cites this paper
• The role of lipid-based signalling in wound healing and senescence.

  2021cites this paper
• 2D perfusion angiography as quantitative method to evaluate iloprost effect on foot circulation.

  2021cites this paper
• Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma

  2020cites this paper
• Maternal dietary fatty acids and their roles in human placental development.

  2020cites this paper
• Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb Ischemia

  2020cites this paper
• PPARs and Angiogenesis—Implications in Pathology

  2020cites this paper
• Eicosanoids in Skin Wound Healing

  2020cites this paper
• In Vivo Choroidal Neovascularization and Macrophage Studies Provide Further Evidence for a Broad Role of Prostacyclin in Angiogenesis

  2019cites this paper
• Prostacyclin synthesis and prostacyclin receptor expression in the porcine corpus luteum: evidence for a luteotropic role in vitro†

  2018influential citation
• The Effect of Iloprost in the Healing of Colonic Anastomosis in Rats under Chemotherapy with Irinotecan.

  2017cites this paper
• Identification of α-helix 4 (α4) of Rab11a as a novel Rab11-binding domain (RBD): Interaction of Rab11a with the Prostacyclin Receptor.

  2017cites this paper
• Long-term clinical outcomes in critical limb ischemia--A retrospective study of 181 patients.

  2016cites this paper
• Role of peroxisome proliferator-activated receptor alpha and gamma in antiangiogenic effect of pomegranate peel extract

  2016cites this paper
• Dietary Fatty Acids and Placentation

  2016cites this paper
• Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells

  2015cites this paper
• The mechanistic basis of prostacyclin and its stable analogues in pulmonary arterial hypertension: Role of membrane versus nuclear receptors.

  2015cites this paper
• Prostanoids regulate angiogenesis acting primarily on IP and EP4 receptors.

  2015cites this paper
• Prostacyclin receptors: Transcriptional regulation and novel signalling mechanisms.

  2015cites this paper
• Maternal Fatty Acids and Their Effects on Placentation

  2015cites this paper
• Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury.

  2014cites this paper
• Physiological functions of peroxisome proliferator-activated receptor β.

  2014cites this paper
• The effects of iloprost on colonic anastomotic healing in rats under obstructive ileus conditions.

  2014cites this paper
• Human endothelial progenitor cells, endothelial dysfunction, hypertension and ACE inhibitors

  2014cites this paper
• Altered Prostanoid Metabolism Contributes to Impaired Angiogenesis in Persistent Pulmonary Hypertension of the Newborn

  2014cites this paper
• Development of a prostacyclin-agonist-eluting aortic stent graft enhancing biological attachment to the aortic wall.

  2014cites this paper
• Targeted Delivery of Carbaprostacyclin to Ischemic Hindlimbs Enhances Adaptive Remodeling of the Microvascular Network

  2013cites this paper
• Prostacyclins.

  2013cites this paper
• Prostacyclin stimulated integrin-dependent angiogenic effects of endothelial progenitor cells and mediated potent circulation recovery in ischemic hind limb model.

  2013cites this paper
• Fatty acid-induced angiogenesis in first trimester placental trophoblast cells: possible roles of cellular fatty acid-binding proteins.

  2013cites this paper
• Chapter The Role of Cyclooxygenases and Lipoxygenases in the Regulation of Tumor Angiogenesis

  2013cites this paper
• Infusion of iloprost without a peristaltic pump: Safety and tolerability

  2013cites this paper
• Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis.

  2013cites this paper
• Molecular Mechanisms Regulating the Vascular Prostacyclin Pathways and Their Adaptation during Pregnancy and in the Newborn

  2012cites this paper
• Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner

  2012cites this paper
• The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis

  2012cites this paper
• Vascular effects of prostacyclin: does activation of PPARδ play a role?

  2012influential citation
• Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2.

  2012cites this paper
• The PPARδ ligand L‐165041 inhibits vegf‐induced angiogenesis, but the antiangiogenic effect is not related to PPARδ

  2012cites this paper
• Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor α/δ Agonist*

  2011cites this paper
• Medical treatment of critical limb ischemia: current state and future directions.

  2011cites this paper
• Prostacyclin and Prostaglandins

  2011cites this paper
• Peroxisome ProliferatorActivated Receptors (PPAR S): A Target with a Broad Therapeutic Potential for Human Diseases: An Overview

  2011cites this paper
• Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis

  2011influential citation
• Peripheral Blood Perfusion Correlates with Microvascular Abnormalities in Systemic Sclerosis: A Laser-Doppler and Nailfold Videocapillaroscopy Study

  2010cites this paper
• Prostacyclin in vascular diseases. - Recent insights and future perspectives -.

  2010cites this paper
• Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs

  2010cites this paper
• The role of prostacyclin in lung cancer.

  2010cites this paper
• Epoprostenol in pulmonary arterial hypertension.

  2009cites this paper
• Chapter 6 The Human Prostacyclin Receptor

  2009cites this paper
• Epoprostenol in pulmonary arterial hypertension

  2009cites this paper
• The human prostacyclin receptor from structure function to disease.

  2009cites this paper
• PPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target

  2009influential citation
• Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease

  2009cites this paper
• Uterine DCs are crucial for decidua formation during embryo implantation in mice.

  2008cites this paper
• Epoprostenol infusion therapy changes angiographic findings of pulmonary arteries in patients with idiopathic pulmonary arterial hypertension.

  2008cites this paper
• Human Follicular Dendritic Cells Interact with T Cells via Expression and Regulation of Cyclooxygenases and Prostaglandin E and I Synthases1

  2008cites this paper
• PPAR-α Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration

  2008cites this paper
• Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturition.

  2008cites this paper
• A Role for PPARβ/δ in Ocular Angiogenesis

  2008cites this paper
• Selective Activation of Peroxisome Proliferator–Activated Receptor (PPAR)α and PPARγ Induces Neoangiogenesis Through a Vascular Endothelial Growth Factor–Dependent Mechanism

  2008influential citation
• Endothelial progenitor cells and angiogenesis join the PPARty.

  2008cites this paper
• Prostacyclin therapies for the treatment of pulmonary arterial hypertension

  2008cites this paper
• Angiogenic Function of Prostacyclin Biosynthesis in Human Endothelial Progenitor Cells

  2008cites this paper
• Selective Activation of PPAR α and PPAR γ Induces Neoangiogenesis through a VEGF-dependent Mechanism

  2008influential citation
• Peroxisome Proliferator-Activated Receptor Alpha Is Crucial for Iloprost-Induced in vivo Angiogenesis and Vascular Endothelial Growth Factor Upregulation

  2008cites this paper
• The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia

  2008cites this paper
• A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart.

  2007cites this paper
• Effect of Iloprost on Impaired Anastomotic Healing Caused by 5-Fluorouracil plus Leucovorin

  2007cites this paper
• Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.

  2007cites this paper
• PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts.

  2007cites this paper
• Prostacyclin, atherothrombosis, and cardiovascular disease.

  2007cites this paper
• Activation of PPAR&bgr;/&dgr; Induces Endothelial Cell Proliferation and Angiogenesis

  2007cites this paper
• Prostacyclin receptor signalling and cell proliferation : role in pulmonary hypertension

  2007cites this paper
• Cardioprotective prostacyclin signaling in vascular smooth muscle.

  2007cites this paper
• Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.

  2006cites this paper
• Possible role of iloprost (stable analog of PG12) in promoting neoangiogenesis in systemic sclerosis.

  2006cites this paper
• RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cells

  2006cites this paper
• Profiling of prostanoids in zebrafish embryonic development.

  2006cites this paper
• Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.

  2006cites this paper
• La terapia medica dell'ischemia critica degli arti inferiori non immediatamente rivascolarizzabile

  2006cites this paper
• Human Follicular Dendritic Cells Express Prostacyclin Synthase: A Novel Mechanism to Control T Cell Numbers in the Germinal Center 1

  2005cites this paper
• Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV).

  2005cites this paper
• Cellular Distribution, Post-translational Modification, and Tumorigenic Potential of Human Group III Secreted Phospholipase A2*

  2005cites this paper
• [Pain management in non-juvenile, aseptic osteonecrosis].

  2004cites this paper
• Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor.

  2004cites this paper
• Schmerztherapie bei nichtjuvenilen, aseptischen Osteonekrosen

  2004cites this paper